Association Between Immune Dysfunction and COVID-19 Breakthrough Infection After SARS-CoV-2 Vaccination in the US-Reference-Cited by-同舟云学术

Association Between Immune Dysfunction and COVID-19 Breakthrough Infection After SARS-CoV-2 Vaccination in the US

Published:2022-02-01 Issue:2 Volume:182 Page:153
ISSN:2168-6106
Container-title:JAMA Internal Medicine
language:en
Short-container-title:JAMA Intern Med

Author:

Sun Jing¹,Zheng Qulu¹,Madhira Vithal²,Olex Amy L.³,Anzalone Alfred J.⁴,Vinson Amanda⁵,Singh Jasvinder A.⁶⁷,French Evan³,Abraham Alison G.⁸,Mathew Jomol⁹,Safdar Nasia¹⁰,Agarwal Gaurav¹¹,Fitzgerald Kathryn C.¹¹²,Singh Namrata¹³,Topaloglu Umit¹⁴,Chute Christopher G.¹¹⁵,Mannon Roslyn B.¹⁶,Kirk Gregory D.¹¹⁷,Patel Rena C.¹⁸,Safo Sandra¹⁹,Patch David A.¹⁹,Haendel Melissa A.¹⁹,Islam Jessica Y.¹⁹,Akselrod Hana¹⁹,Franceschini Nora¹⁹,Chiang Teresa P.¹⁹,Bhattacharyya Sharmodeep¹⁹,Bramante Carolyn¹⁹,Duong Tim¹⁹,Chirischilles Elizabeth A.¹⁹,

Affiliation:

1. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland

2. Palila Software LLC, Reno, Nevada

3. Wright Center for Clinical and Translational Research, Virginia Commonwealth University, Richmond

4. Department of Neurological Sciences, University of Nebraska Medical Center, Omaha

5. Division of Nephrology, Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada

6. Department of Medicine at the School of Medicine, University of Alabama at Birmingham (UAB), Birmingham

7. Department of Epidemiology at the UAB School of Public Health, Birmingham

8. Department of Epidemiology, University of Colorado, Anschutz Medical Campus, Denver

9. Department of Population Health Sciences, University of Wisconsin−Madison School of Medicine and Public Health, Madison

10. Department of Medicine, University of Wisconsin−Madison, Madison

11. Division of Nephrology, Department of Medicine, University of Alabama at Birmingham, Birmingham

12. Department of Neurology, Johns Hopkins University, Baltimore, Maryland

13. Division of Rheumatology, Department of Medicine, University of Washington, Seattle

14. Wake Forest School of Medicine, Winston-Salem, North Carolina

15. School of Medicine, Public Health and Nursing, Johns Hopkins University, Baltimore, Maryland

16. Department of Medicine, University of Nebraska Medical Center, Omaha

17. School of Medicine, Johns Hopkins University, Baltimore, Maryland

18. Division of Allergy and Infectious Diseases, Departments of Medicine and Global Health, University of Washington, Seattle

19. for the National COVID Cohort Collaborative (N3C) Consortium

Publisher

American Medical Association (AMA)

Subject

Internal Medicine

Link

https://jamanetwork.com/journals/jamainternalmedicine/articlepdf/2787643/jamainternal_sun_2021_oi_210075_1643648297.88061.pdf

Reference34 articles.

1. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine.;Polack;N Engl J Med,2020

2. An mRNA vaccine against SARS-CoV-2—preliminary report.;Jackson;N Engl J Med,2020

3. Safety and immunogenicity of two RNA-based Covid-19 vaccine candidates.;Walsh;N Engl J Med,2020

4. Impact of age, ethnicity, sex and prior infection status on immunogenicity following a single dose of the BNT162b2 mRNA COVID-19 vaccine: real-world evidence from healthcare workers, Israel, December 2020 to January 2021.;Abu Jabal;Euro Surveill,2021

5. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data.;Haas;Lancet,2021

Cited by 174 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COVID-19 breakthrough infections among people living with and without HIV: A statewide cohort analysis;International Journal of Infectious Diseases;2024-02

2. Pharmacokinetics Profile and Genetics of Double Antiviral Therapy with Remdesivir and Nirmatrelvir/Ritonavir for Prolonged COVID-19 in Patients Treated with Rituximab: A Real-Life Study and Literature Review;Future Pharmacology;2024-01-24

3. Acute Invasive Pulmonary Aspergillosis: Clinical Presentation and Treatment;Seminars in Respiratory and Critical Care Medicine;2024-01-11

4. Immunomodulators and risk for breakthrough COVID-19 after third SARS-CoV-2 mRNA vaccine among patients with rheumatoid arthritis: a cohort study;Annals of the Rheumatic Diseases;2024-01-10

5. Seroincidence of SARS-CoV-2 infection prior to and during the rollout of vaccines in a community-based prospective cohort of U.S. adults;Scientific Reports;2024-01-05